First study of screening for cognitive impairment in hospitals

April 20, 2012, Indiana University School of Medicine

Neither screening for cognitive impairment nor screening followed by computerized alerts to the health care team improved patient outcome according to the first randomized, controlled study of care provided to hospitalized patients with cognitive impairment.

The study, conducted by researchers from the Regenstrief Institute and Indiana University School of Medicine, screened 998 older adults for within 48 hours of admission to the hospital. Approximately 40 percent were found to have cognitive impairment and were enrolled in the study. The mean age of those with cognitive impairment was 75. Fifty-nine percent were African-American, and 68 percent were female.

"Physicians are bombarded with information," said study first author Malaz Boustani, M.D., MPH, a Regenstrief Institute investigator, associate professor of medicine at the Indiana University School of Medicine and IU Center for Aging Research associate director. "Our study determined that screening for cognitive impairment and providing information to physicians on the best care for patients with cognitive impairment is not the solution to improving care that we seek. We need to consider ways to tackle the difficult task of altering physician behavior. Nationwide, 40 percent of hospitalized older adults have CI, and six out of 10 of these cases are unrecognized. But with the negative findings of this study, we see that we need to think beyond screening; it's not enough.

"If the next step after screening is computerized reminders, we also found that these reminders need to be personalized to both the physician and the patient," said Dr. Boustani, a geriatrician and director of the Healthy Center at Wishard Health Services.

In the study -- which was conducted at Wishard Hospital, a large public institution in Indianapolis -- half of those with cognitive impairment received routine care. Physicians treating the other patients with cognitive impairment received alerts through an electronic medical record system. These alerts advised the physician of the cognitive impairment diagnosis, recommended consultation with a geriatrician, suggested discontinuation of physical restraints, and also advised that the physician not prescribe anticholinergic drugs.

Anticholinergics block acetylcholine, a nervous system neurotransmitter, and are widely used for hypertension, congestive heart failure and other health issues common to older adults. Previous studies by Dr. Boustani and colleagues in the U.S. and U.K. have linked this class of drugs with cognitive impairment.

The simple computerized alerts did not significantly change physician behavior. Referrals for geriatric consultation did not increase. Use of physical restraints did not diminish. Anticholinergics continued to be prescribed at the same rate as the control group.

The combination of screening plus computerized alerts had no impact on health outcomes, did not decrease mortality, and did not improve recognition of cognitive impairment at hospital discharge according to the study findings.

"In previous work, Regenstrief Institute investigators have definitively shown that computer-generated reminders and care suggestions can have substantial impact on doctors' provision of preventive care, such as ordering mammograms," said Regenstrief Institute President William Tierney, M.D, associate dean for clinical effectiveness research at the IU School of Medicine and an international leader in biomedical informatics and health services research. "However, computers and electronic health records often don't help doctors make difficult decisions about treating complex chronic conditions such as impaired cognition in the elderly. Doctors' decisions require more detailed thinking and support beyond simply reminding them about their patients' conditions and care they might need. It may also be that doctors don't mind computers helping them with preventive care but balk when computers try to tell them how to treat their chronically ill patients."

"Enhancing Care for Hospitalized Older Adults With Cognitive Impairment: A Randomized Controlled Trial" appears in the May 2012 issue of the Journal of General Internal Medicine.

Explore further: Even mild cognitive impairment appears to substantially increase risk for death

Related Stories

Even mild cognitive impairment appears to substantially increase risk for death

September 5, 2011
Cognitive impairment, even when detected at an early, mild stage, is a significant predictor of decreased life expectancy.

Cognitive impairment in older adults often unrecognized in the primary care setting

February 13, 2012
A new study published in the Journal of the American Geriatrics Society reveals that brief cognitive screenings combined with offering further evaluation increased new diagnoses of cognitive impairment in older veterans two ...

Common drugs linked to cognitive impairment and possibly to increased risk of death

June 24, 2011
A large, long-term study confirms that medications with anticholinergic activity, which include many drugs frequently taken by older adults, cause cognitive impairment. The research is also the first to identify a possible ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.